Source:http://linkedlifedata.com/resource/pubmed/id/21263052
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-22
|
pubmed:abstractText |
Ten participants attending elective anterior segment eye surgery received 0.5% caspofungin eye drops either 1 drop hourly for 4 h or 1 drop an hour before surgery. The eye drops were generally well tolerated. In the absence of inflammation or corneal abrasion, topical caspofungin does not achieve clinically relevant concentrations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1098-6596
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1761-3
|
pubmed:dateRevised |
2011-10-3
|
pubmed:meshHeading |
pubmed-meshheading:21263052-Aged,
pubmed-meshheading:21263052-Aged, 80 and over,
pubmed-meshheading:21263052-Aqueous Humor,
pubmed-meshheading:21263052-Echinocandins,
pubmed-meshheading:21263052-Female,
pubmed-meshheading:21263052-Humans,
pubmed-meshheading:21263052-Male,
pubmed-meshheading:21263052-Middle Aged,
pubmed-meshheading:21263052-Ophthalmic Solutions
|
pubmed:year |
2011
|
pubmed:articleTitle |
Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous humor.
|
pubmed:affiliation |
Department of Pharmacy Practice, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|